Page last updated: 2024-08-21

glycyrrhizic acid and Chronic Lung Injury

glycyrrhizic acid has been researched along with Chronic Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Deng, J; Du, J; Gu, J; Jiang, B; Peng, G; Ran, X; Wen, D; Xia, F; Zhang, A1
Chen, C; Chen, J; Chen, Y; Dong, N; Feng, L; Liu, L; Qian, Y; Shi, Q; Wang, B1

Other Studies

2 other study(ies) available for glycyrrhizic acid and Chronic Lung Injury

ArticleYear
Glycyrrhizin alleviates sepsis-induced acute respiratory distress syndrome via suppressing of HMGB1/TLR9 pathways and neutrophils extracellular traps formation.
    International immunopharmacology, 2022, Volume: 108

    Topics: Animals; Disease Models, Animal; Extracellular Traps; Glycyrrhizic Acid; HMGB1 Protein; Lung; Lung Injury; Mice; Myeloid Differentiation Factor 88; Neutrophils; Respiratory Distress Syndrome; Sepsis; Toll-Like Receptor 9

2022
Glycyrrhizin protects against particulate matter-induced lung injury via regulation of endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis through Nrf2/HO-1/NQO1 signaling pathway.
    International immunopharmacology, 2023, Volume: 120

    Topics: Animals; Endoplasmic Reticulum Stress; Glycyrrhizic Acid; Humans; Inflammasomes; Lung Injury; Mice; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Particulate Matter; Pyroptosis; Signal Transduction

2023